The impact of medication regimen factors on adherence to chronic treatment: a review of literature

This article reviews recent literature in chronic illness or long-term health management including asthma, contraception, diabetes, HIV disease, and hypertension/cardiovascular disease, mental disorders, pain, and other diseases to determine the relationship between regimen factors and adherence to medications. The authors conducted an electronic literature search to detect articles published between 1998 and 2007. Articles were included if they pertained to a chronic illness or to contraception, included a clear definition of how adherence was measured, and included regimen factors as primary or secondary explanatory variables. Methodology of the studies varied greatly, as did methods of measuring adherence and regimen factors. Surprisingly few of these articles concerned (1) chronic treatment, (2) regimen factors such as dosing, pill burden, and regimen complexity, and (3) adherence measured in a clear manner. Most studies failed to use state-of-the-art methods of measuring adherence. Despite these flaws, a suggestive pattern of the importance of regimen factors, specifically dose frequency and regimen complexity, emerged from this review.

[1]  P. Masand Tolerability and adherence issues in antidepressant therapy. , 2003, Clinical therapeutics.

[2]  Antonio Addis,et al.  Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. , 2002, Clinical therapeutics.

[3]  B. Gazzard,et al.  Better maintained adherence on switching from twice‐daily to once‐daily therapy for HIV: a 24‐week randomized trial of treatment simplification using stavudine prolonged‐release capsules , 2005, HIV medicine.

[4]  J. Mullen,et al.  A Random-Assignment, Double-Blind, Clinical Trial of Once- vs Twice-Daily Administration of Quetiapine Fumarate in Patients with Schizophrenia or Schizoaffective Disorder: A Pilot Study , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[5]  D. Roter,et al.  Patient adherence to HIV medication regimens: a review of published and abstract reports. , 2002, Patient education and counseling.

[6]  W. Marelich,et al.  Barriers to antiretroviral adherence among HIV-infected adults. , 2000, AIDS patient care and STDs.

[7]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[8]  J. Tolson,et al.  Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection , 2000, AIDS.

[9]  C. Hinkin,et al.  Medication adherence among HIV+ adults , 2002, Neurology.

[10]  E. Yiannakopoulou,et al.  Adherence to antihypertensive treatment: a critical factor for blood pressure control. , 2005 .

[11]  Loren G. Miller,et al.  A prospective study of predictors of adherence to combination antiretroviral medication , 2002, Journal of General Internal Medicine.

[12]  A. d’Arminio Monforte,et al.  Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity , 2003, Neurology.

[13]  A. Kaplan,et al.  Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J R Ickovics,et al.  Adherence in AIDS clinical trials: a framework for clinical research and clinical care. , 1997, Journal of clinical epidemiology.

[15]  Anke Richter,et al.  The impact of reducing dose frequency on health outcomes. , 2003, Clinical therapeutics.

[16]  A. Peterson,et al.  Meta-analysis of trials of interventions to improve medication adherence. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[17]  Gary Marks,et al.  Efficacy of Interventions in Improving Highly Active Antiretroviral Therapy Adherence and HIV-1 RNA Viral Load: A Meta-Analytic Review of Randomized Controlled Trials , 2006, Journal of acquired immune deficiency syndromes.

[18]  Richard H. Chapman,et al.  Predictors of adherence with antihypertensive and lipid-lowering therapy. , 2005 .

[19]  E. V. van Ameijden,et al.  DRUG USERS AND HIV-COMBINATION THERAPY (HAART): FACTORS WHICH IMPEDE OR FACILITATE ADHERENCE , 2002, Substance use & misuse.

[20]  E. Funkhouser,et al.  Patient-perceived barriers to antiretroviral adherence: Associations with race , 2002, AIDS care.

[21]  J. Berlin,et al.  Patient misunderstanding of dosing instructions , 1996, Journal of General Internal Medicine.

[22]  Susan Swindells,et al.  Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.

[23]  S. Adlis,et al.  Comparison of patients' compliance with prescribed oral and inhaled asthma medications. , 1994, Archives of internal medicine.

[24]  D. Spiegelman,et al.  Patterns of Adherence With Antiretroviral Medications: An Examination of Between‐Medication Differences , 2001, Journal of acquired immune deficiency syndromes.

[25]  Keith C. Norris,et al.  Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. , 1996, American journal of hypertension.

[26]  Johnson George,et al.  Development and Validation of the Medication Regimen Complexity Index , 2004, The Annals of pharmacotherapy.

[27]  S. Calabrese,et al.  The Antiretroviral Regimen Complexity Index: A Novel Method of Quantifying Regimen Complexity , 2007, Journal of acquired immune deficiency syndromes.

[28]  B. Pinter Continuation and compliance of contraceptive use , 2002, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[29]  H. Mcdonald,et al.  Interventions to enhance patient adherence to medication prescriptions: scientific review. , 2002, JAMA.

[30]  M. Purucker,et al.  Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day. , 2003, Chest.

[31]  D. Apter,et al.  Efficacy, Cycle Control, and User Acceptability of a Novel Combined Contraceptive Vaginal Ring , 2002, Obstetrics and gynecology.

[32]  O. Ganda,et al.  Migration and its impact on adiposity and type 2 diabetes. , 2007, Nutrition.

[33]  P. Kardas,et al.  The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes) , 2005, Diabetes, obesity & metabolism.

[34]  V. Stone,et al.  Antiretroviral Regimen Complexity, Self‐Reported Adherence, and HIV Patients' Understanding of Their Regimens: Survey of Women in the HER Study , 2001, Journal of acquired immune deficiency syndromes.

[35]  Thomas E. Freese,et al.  Patient Characteristics, HIV Serostatus, and Risk Behaviors Among Gay and Bisexual Males Seeking Treatment for Methamphetamine Abuse and Dependence in Los Angeles , 2001, Journal of addictive diseases.

[36]  L. Gerald,et al.  Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. , 2008, Contemporary clinical trials.

[37]  C. J. McGrath,et al.  Effect of exchange rate return on volatility spill-over across trading regions , 2012 .

[38]  F. Brun-Vézinet,et al.  Adherence to Antiretroviral Therapy and Outcomes in HIV-Infected Patients Enrolled in An Induction/Maintenance Randomized Trial , 2001, Antiviral therapy.

[39]  Nicholas F Taylor,et al.  …But Watch Out for the Weather: FACTORS AFFECTING ADHERENCE TO PROGRESSIVE RESISTANCE EXERCISE FOR PERSONS WITH COPD , 2007, Journal of cardiopulmonary rehabilitation and prevention.

[40]  J. George,et al.  Predictors of refill non-adherence in patients with heart failure. , 2007, British journal of clinical pharmacology.

[41]  J. Morley,et al.  Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial , 2003, Palliative medicine.

[42]  C Inch,et al.  Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. , 2006, The Cochrane database of systematic reviews.

[43]  A. Fisher,et al.  Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study. , 2002, American journal of obstetrics and gynecology.

[44]  J. Stoner,et al.  Patterns of adherence to antiretroviral medications: the value of electronic monitoring , 2003, AIDS.

[45]  C. Nemeroff,et al.  Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression. , 2002, The Journal of clinical psychiatry.

[46]  G. Tataronis,et al.  A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. , 1999, Archives of internal medicine.

[47]  R. Goldberg,et al.  Discrepancies in the use of medications: their extent and predictors in an outpatient practice. , 2000, Archives of internal medicine.

[48]  R Brian Haynes,et al.  Helping patients follow prescribed treatment: clinical applications. , 2002, JAMA.

[49]  S. Caillat-Zucman,et al.  Prospective screening for human leukocyte antigen-B*5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population. , 2007, Journal of acquired immune deficiency syndromes.

[50]  S. Sereika,et al.  Medication Adherence in Persons With Cardiovascular Disease , 2003, The Journal of cardiovascular nursing.

[51]  Ryan O'Donnell,et al.  Beyond compliance. , 2007, Occupational health & safety.

[52]  A. Paes,et al.  Impact of Dosage Frequency on Patient Compliance , 1997, Diabetes Care.

[53]  A. Molassiotis,et al.  A pilot study of the effects of a behavioural intervention on treatment adherence in HIV-infected patients , 2003, AIDS care.

[54]  D. Nevedal,et al.  What is a missed dose? Implications for construct validity and patient adherence , 2007, AIDS care.

[55]  J. Parsons,et al.  Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men , 2003, AIDS care.

[56]  R. Kubacka,et al.  Attitudes of patients with hypertension or arthritis toward the frequency of medication administration. , 1985, American journal of hospital pharmacy.

[57]  R S Woodward,et al.  The effect of prescribed daily dose frequency on patient medication compliance. , 1990, Archives of internal medicine.

[58]  N. Hagen,et al.  Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain , 1994, Cancer.

[59]  Blair T. Johnson,et al.  Efficacy of Antiretroviral Therapy Adherence Interventions: A Research Synthesis of Trials, 1996 to 2004 , 2006, Journal of acquired immune deficiency syndromes.

[60]  S. Kane Systematic review: adherence issues in the treatment of ulcerative colitis , 2006, Alimentary pharmacology & therapeutics.

[61]  W. Bailey,et al.  Medication adherence patterns in chronic obstructive pulmonary disease. , 1991, Chest.

[62]  R. Lydiard Irritable bowel syndrome, anxiety, and depression: what are the links? , 2001, The Journal of clinical psychiatry.

[63]  P. Donnan,et al.  Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[64]  A. Wu,et al.  Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[65]  M. Tran,et al.  Effects of Once-Daily and Twice-Daily Dosing on Adherence With Prescribed Glipizide Oral Therapy for Type 2 Diabetes , 2002, Southern medical journal.

[66]  J. Cramer,et al.  A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.

[67]  A. Antinori,et al.  Treatment‐Related Factors and Highly Active Antiretroviral Therapy Adherence , 2002, Journal of acquired immune deficiency syndromes.

[68]  Brigitte L. Sicat Ortho Evra, a New Contraceptive Patch , 2003, Pharmacotherapy.

[69]  D. Singer,et al.  Polypharmacy and medication adherence in patients with type 2 diabetes. , 2003, Diabetes care.

[70]  R. Zuwallack,et al.  A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. , 1992, Chest.